PriceSensitive

New Leaf Ventures (CSE:NLV) launches DAMA HEMP CBD branded product lineup

Cannabis
CSE:NLV
17 February 2021 15:00 (EST)

New Leaf Ventures Inc. (NLV) has launched a new nationwide CBD-only product line under its highly popular premier Dama Brand.

The company’s Dama Brand product team has announced plans for entry into the growing CBD marketplace. The proposed lineup will feature herbal blend tinctures, soft gels, and topicals.

These proposed high-quality hemp products will benefit from a nationwide rollout launching in Q1 2021. The new products will be marketed directly to consumers through an e-commerce platform and wholesaled to multi-outlet grocery and pharmacy retailers.

With growing global consumer interest in the CBD market, particular emphasis on source-origin and attention to high-grade cultivation and premium nutrient inputs are paramount to meeting the criteria of well-informed health-conscious individuals.

New Leaf Ventures brings decades of extensive cannabis industry knowledge to understand and choose the best formulations. The team’s passion for the healing properties of the hemp plant brings great pride and excitement to supply consumers not only in Washington but across the entire United States.

New Leaf USA and Director of New Leaf Ventures Inc. CEO Dax Colwell said the CBD market is evolving and expanding.

“We can educate consumers about the benefits of different cannabinoids and holistic plant science with a trusted, safe, effective product.”

In November of last year, New Leaf announced the development of a CBD beverage, and this latest project will round out and extend the overall product offering to retailers and consumers alike.

The company’s commitment to CBD extends co-founder Dax Colwell’s personal vision. He has been a champion of CBD since he launched ‘Leaf of Hope’ in November 2013 for 30 families that provided at-risk children with a CBD-rich strain of cannabis known as AC/DC.

Children in the program ranged in age from 3-20, most of whom are suffering from intractable epilepsy diagnoses. The results from the program were incredibly positive, seeing a reduction in seizure frequency in addition to tremendous quality of life improvements.

CBD is a non-psychoactive cannabinoid, native to Cannabis. Hemp products are classified through the FDA as containing less than .3 per cent THC.

Mounting scientific evidence is supporting the anecdotal efficacy of CBD regarding a host of disorders. Products will include plant based herbal formulations designed for wellness, balance, reduction of stress, and body tension.

New Leaf Ventures Inc. is developing a cannabis sector-based scalable securities concept of focused financing and applied management to achieve earnings growth through targeted investment.

New Leaf Ventures Inc. is up 7.69 per cent to C$0.70 per share.

Related News